The American Society of Hematology shared a post on X:
“Variants of Unknown Clinical Significance (VUS) challenge labs, clinicians, and genetic counselors.
Join ASH’s Precision Hematology webinar on Friday, May 30 to learn strategies for evaluating VUS in germline testing.
Register now.”
Register here.
More posts featuring ASH on OncoDaily.